SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)
[v167082_ex99-1.htm 2 EX-99.1]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: v167082_ex99-1.htm 2 EX-99.1
[v167082_ex99-1.htm 2 EX-99.1]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company Buyer Buyers Parties Party BACKGROUND WHEREAS 1933 Act Regulation D SEC WHEREAS Series B Preferred Stock Common Stock Securities WHEREAS NOW, THEREFORE Article 1 INCORPORATION BY REFERENCE AND DEFINITIONS 1.1 Incorporation by Reference 1.2 Supersedes Other Agreements 1.3 Certain Definitions PAGE 1 1.3.1 9.9% Limitation “ 1.3.2 1933 Act “ 1.3.3 “]
BSPM [Biostar Pharmaceuticals,] 8-K: SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company
[SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company Buyer Buyers Parties Party BACKGROUND WHEREAS 1933 Act Regulation D SEC WHEREAS Series B Preferred Stock Common Stock Securities WHEREAS NOW, THEREFORE Article 1 INCORPORATION BY REFERENCE AND DEFINITIONS 1.1 Incorporation by Reference 1.2 Supersedes Other Agreements 1.3 Certain Definitions PAGE 1 1.3.1 9.9% Limitation “ 1.3.2 1933 Act “ 1.3.3 “]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[SECURITIES PURCHASEREEMENT SECURITIES PURCHASEREEMENTreementmpany Buyer Buyers Parties Party BACKGROUND WHEREAS 1933 Act Regulation D SEC WHEREAS Series B Preferred Stockmmon Stock Securities WHEREAS NOW, THEREFORE Article 1ORPORATION BY REFERENCE AND DEFINITIONS 1.1orporation by Reference 1.2 Supersedes Otherreements 1.3 Certain Definitions PAGE 1 1.3.1]
BSPM [Biostar Pharmaceuticals,] 8-K: SECURITIES PURCHASEREEMENT SECURITIES PURCHASEREEMENTreementmpany Buyer Buyers Parties Party
[SECURITIES PURCHASEREEMENT SECURITIES PURCHASEREEMENTreementmpany Buyer Buyers Parties Party BACKGROUND WHEREAS 1933 Act Regulation D SEC WHEREAS Series B Preferred Stockmmon Stock Securities WHEREAS NOW, THEREFORE Article 1ORPORATION BY REFERENCE AND DEFINITIONS 1.1orporation by Reference 1.2 Supersedes Otherreements 1.3 Certain Definitions PAGE 1 1.3.1]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Reports Unaudited Third Quarter 2009 Financial Results - Conference call scheduled Monday, November 16, 2009 at 9:00 a.m. ET - BEIJING, Nov. 15 /PRNewswire-Asia/ Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today its unaudited financial results for the three-month and nine-month periods ended September 30, 2009. Financial Highlights · Sales for the] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]
SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited Third Quarter 2009 Financial Results
[Sinovac Reports Unaudited Third Quarter 2009 Financial Results - Conference call scheduled Monday, November 16, 2009 at 9:00 a.m. ET - BEIJING, Nov. 15 /PRNewswire-Asia/ Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today its unaudited financial results for the three-month and nine-month periods ended September 30, 2009. Financial Highlights · Sales for the] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]
SVA [SINOVAC BIOTECH] F-3: (Original Filing)
[Law Debenture Corporate Services Inc. Copies to: st David T. Zhang, Esq. Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement. o ý o o o o CALCULATION OF REGISTRATION FEE] [[Letterhead of Rhudd & Associates] November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 Peoples Republic of China Dear Sirs, Sinovac Biotech Ltd. (the Company) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the Prospectus) contained] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road Haidian District, Beijing 100085 Peoples Republic of China Ladies and Gentlemen: Company Securities Registration Statement We have acted as special U.S. counsel to Sinovac Biotech Ltd., a limited liability corporation incorporated in Antigua, West Indies (the The facts, as we understand them, and upon which with your permission we] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 Peoples Republic of China Dear Sirs, Sinovac Biotech Ltd. (the Company) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the Prospectus) contained in the Registration Statement. We] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Vancouver, Canada, November 18, 2009 Chartered Accountants]
SVA [SINOVAC BIOTECH] F-3: Law Debenture Corporate Services Inc. Copies to: st
[Law Debenture Corporate Services Inc. Copies to: st David T. Zhang, Esq. Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement. o ý o o o o CALCULATION OF REGISTRATION FEE] [[Letterhead of Rhudd & Associates] November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 Peoples Republic of China Dear Sirs, Sinovac Biotech Ltd. (the Company) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the Prospectus) contained] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road Haidian District, Beijing 100085 Peoples Republic of China Ladies and Gentlemen: Company Securities Registration Statement We have acted as special U.S. counsel to Sinovac Biotech Ltd., a limited liability corporation incorporated in Antigua, West Indies (the The facts, as we understand them, and upon which with your permission we] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 Peoples Republic of China Dear Sirs, Sinovac Biotech Ltd. (the Company) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the Prospectus) contained in the Registration Statement. We] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Vancouver, Canada, November 18, 2009 Chartered Accountants]
